Rockwell Medical, Inc. (NASDAQ:RMTI) Shares Sold by Richmond Brothers Inc.

Richmond Brothers Inc. cut its position in shares of Rockwell Medical, Inc. (NASDAQ:RMTI - Free Report) by 86.9% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 32,682 shares of the company's stock after selling 217,190 shares during the period. Richmond Brothers Inc. owned approximately 0.10% of Rockwell Medical worth $67,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the business. Jane Street Group LLC acquired a new position in shares of Rockwell Medical in the third quarter valued at approximately $534,000. Walleye Capital LLC purchased a new position in Rockwell Medical in the third quarter valued at $435,000. Corsair Capital Management L.P. acquired a new stake in Rockwell Medical in the third quarter valued at $298,000. JPMorgan Chase & Co. increased its holdings in shares of Rockwell Medical by 134,397.1% in the 3rd quarter. JPMorgan Chase & Co. now owns 47,074 shares of the company's stock valued at $187,000 after acquiring an additional 47,039 shares during the last quarter. Finally, HighTower Advisors LLC raised its position in shares of Rockwell Medical by 75.6% during the 3rd quarter. HighTower Advisors LLC now owns 57,413 shares of the company's stock worth $228,000 after acquiring an additional 24,715 shares in the last quarter. Hedge funds and other institutional investors own 23.31% of the company's stock.

Analyst Ratings Changes

A number of brokerages recently issued reports on RMTI. HC Wainwright reaffirmed a "buy" rating and issued a $7.00 price target on shares of Rockwell Medical in a report on Monday, December 23rd. StockNews.com downgraded shares of Rockwell Medical from a "buy" rating to a "hold" rating in a research report on Friday, December 20th.

Remove Ads

Rockwell Medical Stock Performance

RMTI traded down $0.05 on Friday, hitting $1.35. 656,192 shares of the company traded hands, compared to its average volume of 408,840. Rockwell Medical, Inc. has a 12-month low of $1.26 and a 12-month high of $5.15. The company has a quick ratio of 2.00, a current ratio of 2.41 and a debt-to-equity ratio of 0.33. The company has a 50 day moving average of $1.85 and a 200-day moving average of $2.61. The stock has a market capitalization of $43.63 million, a PE ratio of -27.00 and a beta of 1.55.

Rockwell Medical (NASDAQ:RMTI - Get Free Report) last announced its quarterly earnings results on Thursday, March 20th. The company reported ($0.02) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.02 by ($0.04). The business had revenue of $24.67 million during the quarter, compared to analysts' expectations of $23.65 million. Rockwell Medical had a negative net margin of 1.25% and a positive return on equity of 8.55%. Sell-side analysts anticipate that Rockwell Medical, Inc. will post 0.03 earnings per share for the current year.

Rockwell Medical Profile

Rockwell Medical, Inc, together with its subsidiaries, operates as a healthcare company that engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. The company offers Triferic Dialysate and Triferic AVNU which are indicated to maintain hemoglobin in adult undergoing hemodialysis.